Gateway for Cancer Research (Gateway) is a nonprofit 501(c)(3) organization committed to funding innovative cancer research. Thanks to generous underwriting, 99 cents of every dollar Gateway receives directly funds Phase I and Phase II treatment-based investigator initiated clinical trials treating cancer. Since 1991, Gateway has supported more than 195 clinical trials and funded over $95 million in breakthrough cancer research. The American Lung Association (ALA) pioneered the model of education, advocacy and research to address public health issues. For more than a century, the American Lung Association has advanced medical and scientific research to improve the quality of life for lung disease patients and their families through our groundbreaking research. The Association’s LUNG FORCE unites individuals and their loved ones across the country to stand together for lung health and against lung cancer, the number one cancer killer in the U.S. In support of that effort, we continue to support trailblazing research, novel ideas, and innovative approaches with the hope of eliminating lung cancer and improving early diagnostic methods for those at risk.
PURPOSE
Gateway is partnering with ALA to fund innovative lung cancer clinical trials. We are looking for applications focused on one of the following topics. (1) Early detection diagnostics (2) Metastatic disease